JPRN-jRCT1080222730未知Unknown
Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritis
Toyama Chemical Co., Ltd. (Current FUJIFILM Toyama Chemical Co., Ltd.)0 个研究点目标入组 2,000 人开始时间: 2015年1月29日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with rheumatoid arthritis
- •All patients who take iguratimod
排除标准
- •Pregnant women or women suspected of being pregnant
- •Patients with a serious liver disorder
- •Patients with peptic ulcer
- •Patients with known hypersensitivity to iguratimod or any of its
- •Patients receiving treatment with warfarin
研究者
相似试验
未知
Unknown
Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritisRheumatoid ArthritisJPRN-jRCT1080222005Eisai Co., Ltd.2,000
尚未招募
Unknown
Investigation of the clinical safety and efficacy of favipiravir (Avigan tablets) in patients with novel or re-emerging influenza virus infectionsJPRN-jRCT1080223849FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)
已完成
Unknown
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic SeizuresEpilepsyJPRN-jRCT1080224672Eisai Co., Ltd.500
已完成
Unknown
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic SeizuresEpilepsyJPRN-jRCT1080224671Eisai Co., Ltd.3,750
撤回
不适用
Clinical investigation of the safety and efficacy of ALIMAXX-B biliary stent for bile duct obstructioCBD obstructionmalignant biliary obstruction10018008NL-OMON31943Alveolus, Inc.10